Pharmaceutical Executive December 2, 2024
The latest news for pharma industry insiders.
ROI and Rare Disease: Retooling the ‘Gene’ Value Machine
Framework proposes three strategies designed to address the unique challenges of personalized and genetic therapies for rare diseases—and increase the probability of economic success for a new wave of potential curative treatments for these conditions.
Health Plan Design Challenges and the Impact of HSAs on Healthcare Use
Paul Fronstin, director of Health Benefits Research at EBRI, spoke with MHE about the challenges employers face in incentivizing high-value healthcare while managing costs.
Trump’s Trade Chief Advocates ‘Strategic Decoupling’ From China
President-elect Donald Trump’s pick for the top trade position sees China as a “generational challenge” to the US and has advocated for a strategic decoupling...
Today's Sponsors
Today's Sponsor